If the FDA was sincere about doing no harm would they not approve on condition that any patient that doesn't respond as predicted gets a second and/or third doses from different batches at no additional cost?
If approved on that basis Mesoblast could rework costs to allow for additional doses when required and get on with saving as many children's lives as possible!
Ann: Mesoblast Type A Meeting with FDA, page-51
-
- There are more pages in this discussion • 524 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.5¢ |
Change
0.020(2.16%) |
Mkt cap ! $1.101B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 96.5¢ | 93.5¢ | $2.401M | 2.516M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 128056 | 94.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 29271 | 17 |
View Market Depth
| Last trade - 12.14pm 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |